文献速递产科母胎医学

COVID-19对英国妊娠期糖尿病妊娠结局的影响:一项多中心回顾性队列研究

Impact of COVID-19 on gestational diabetes pregnancy outcomes in the UK: A multicentre retrospective cohort study.
PubMed 文献 · BJOG · 2023-11-15

该多中心回顾性队列研究纳入疫情前4915例和疫情期间3467例妊娠期糖尿病(GDM)孕妇,评估紧急照护路径对筛查、诊断和管理的影响。新诊断标准更多识别出经产妇、高BMI和更贫困的GDM孕妇,且既往GDM史较少(均p<0.05);疫情期间关键结局无差异。3%孕妇在产前登记时发现已有糖尿病。作者建议有GDM危险因素的孕妇在早孕期接受HbA1c筛查。

要点

  • 新诊断标准更多识别经产妇、高BMI和更贫困的GDM孕妇,既往GDM史较少(均p<0.05)。
  • 疫情期间GDM孕妇的关键结局指标与疫情前无差异。
  • 3%孕妇在产前登记时发现已有糖尿病,作者建议有GDM危险因素者早孕期筛查HbA1c。

核心结论

  • 疫情期间使用HbA1c和空腹血糖识别出更高风险的GDM人群,但对妊娠结局影响极小。
  • 未诊断的已有糖尿病患病率高,作者建议有GDM危险因素的孕妇在早孕期接受HbA1c筛查。

研究设计与样本

  • 回顾性多中心队列研究,纳入英格兰和苏格兰9个国民健康服务体系(NHS)医院信托/健康委员会。
  • 疫情前(2018年4月1日至2020年3月31日)4915例GDM孕妇,疫情期间(2020年5月1日至2021年3月31日)3467例GDM孕妇。

主要发现

  • 新诊断标准更多识别经产妇、高BMI和更贫困的GDM孕妇,且既往GDM史较少(均p<0.05)。
  • 疫情期间这些GDM孕妇的关键结局指标无差异。
  • 3%孕妇在产前登记时发现已有糖尿病。
  • 疫情期间继续口服葡萄糖耐量试验(OGTT)但引入虚拟照护者,疫情前后结局也相似。

临床怎么用

  • 作者建议有GDM危险因素的孕妇在早孕期接受HbA1c筛查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the impact of implementing emergency care pathway(s) for screening, diagnosing and managing women with gestational diabetes (GDM) during COVID-19. DESIGN: Retrospective multicentre cohort. SETTING: Nine National Health Service (NHS) Hospital Trusts/Health boards in England and Scotland. POPULATION: 4915 women with GDM pre-pandemic (1 April 2018 to 31 March 2020), and 3467 women with GDM during the pandemic (1 May 2020 to 31 March 2021). METHODS: We examined clinical outcomes for women with GDM prior to and during the pandemic following changes in screening methods, diagnostic testing, glucose thresholds and introduction of virtual care for monitoring of antenatal glycaemia. MAIN OUTCOME MEASURES: Intervention at birth, perinatal mortality, large-for-gestational-age infants and neonatal unit admission. RESULTS: The new diagnostic criteria more often identified GDM women who were multiparous, had higher body mass index (BMI) and greater deprivation, and less frequently had previous GDM (all p < 0.05). During COVID, these women had no differences in the key outcome measures. Of the women, 3% were identified with pre-existing diabetes at antenatal booking. Where OGTT continued during COVID, but virtual care was introduced, outcomes were also similar pre- and during the pandemic. CONCLUSIONS: Using HbA1c and fasting glucose identified a higher risk GDM population during the pandemic but this had minimal impact on pregnancy outcomes. The high prevalence of undiagnosed pre-existing diabetes suggests that women with GDM risk factors should be offered HbA1c screening in early pregnancy.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Mclennan NM, Lindsay R, Saravanan P, et al. Impact of COVID-19 on gestational diabetes pregnancy outcomes in the UK: A multicentre retrospective cohort study. BJOG. 2023. PMID: 37968246. doi:10.1111/1471-0528.17716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。